 | Up a level |
Antiretroviral, Therapy in Low-Income Countries Collaboration of the Internation; Cohort Collaboration, ART; Brinkhof, MW; Egger, M; Boulle, A; May, M; Hosseinipour, M; Sprinz, E; Braitstein, P; Dabis, F; Reiss, P; Bangsberg, DR; Rickenbach, M; Miro, JM; Myer, L; Mocroft, A; Nash, D; Keiser, O; Pascoe, M; van der Borght, S; ... (2007). Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical infectious diseases, 45(11), pp. 1518-21. Cary, N.C.: Oxford University Press 10.1086/522986
Braitstein, P; Brinkhof, MW; Dabis, F; Schechter, M; Boulle, A; Miotti, P; Wood, R; Laurent, C; Sprinz, E; Seyler, C; Bangsberg, DR; Balestre, E; Sterne, JA; May, M; Egger, M; Antiretroviral, Therapy in Lower Income Countries (ART-LINC) Collaboration; Cohort Collaboration (ART-CC) groups, ART (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet, 367(9513), pp. 817-824. London: Elsevier 10.1016/S0140-6736(06)69886-3
